Celldex Therapeutics, Inc. Business Finance Contracts & Agreements

54 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Underwriting Agreement between Celldex Therapeutics, Inc. and Underwriters (Leerink Partners LLC, Cowen and Company, LLC) for 8,520,000 Shares of Common Stock
Underwriting Agreements
Celldex Therapeutics, Inc.
Biotechnology
NY
2024
Controlled Equity Offering Sales Agreement between Celldex Therapeutics, Inc. and Cantor Fitzgerald & Co. (February 26, 2024)
Equity Distribution Agreements
Celldex Therapeutics, Inc.
Biotechnology
NY
2024
Underwriting Agreement between Celldex Therapeutics, Inc. and Jefferies LLC and Leerink Partners LLC for Sale of Common Stock
Underwriting Agreements
Celldex Therapeutics, Inc.
Biotechnology
NY
2023
Description of Celldex Therapeutics, Inc. Common Stock Registered Under Section 12 of the Exchange Act
Stock Agreements
Celldex Therapeutics, Inc.
Biotechnology
2023
Underwriting Agreement between Celldex Therapeutics, Inc. and Jefferies LLC, SVB Leerink LLC (July 13, 2021)
Underwriting Agreements
Celldex Therapeutics, Inc.
Biotechnology
NY
2021
Celldex Therapeutics, Inc. Nonqualified Stock Option Grant Agreement with Optionee
Warrant Agreements
Celldex Therapeutics, Inc.
Biotechnology
DE
2021
Celldex Therapeutics, Inc. Restricted Stock Award Agreement with Awardee under 2021 Omnibus Equity Incentive Plan
Equity Distribution Agreements
Celldex Therapeutics, Inc.
Biotechnology
DE
2021
Celldex Therapeutics, Inc. 2008 Stock Option and Incentive Plan (Amended and Restated as of June 15, 2017)
Stock Agreements
Celldex Therapeutics, Inc.
Biotechnology
DE
2020
Underwriting Agreement between Celldex Therapeutics, Inc. and Cantor Fitzgerald & Co. (June 15, 2020)
Underwriting Agreements
Celldex Therapeutics, Inc.
Biotechnology
NY
2020
Description of Celldex Therapeutics, Inc. Common Stock Registered Under Section 12 of the Exchange Act
Stock Agreements
Celldex Therapeutics, Inc.
Biotechnology
2020
Celldex Therapeutics, Inc. Amended and Restated 2004 Employee Stock Purchase Plan (Effective June 19, 2019)
Equity Distribution Agreements
Celldex Therapeutics, Inc.
Biotechnology
2019
Celldex Therapeutics, Inc. Non-Qualified Stock Option Agreement with Employee
Stock Agreements
Celldex Therapeutics, Inc.
Biotechnology
2018
Celldex Therapeutics, Inc. 2004 Employee Stock Purchase Plan (as amended June 15, 2017)
Stock Agreements
Celldex Therapeutics, Inc.
Biotechnology
2018
Controlled Equity Offering Sales Agreement between Celldex Therapeutics, Inc. and Cantor Fitzgerald & Co. (May 19, 2016)
Equity Distribution Agreements
Celldex Therapeutics, Inc.
Biotechnology
NY
2016
Underwriting Agreement between Celldex Therapeutics, Inc. and Jefferies LLC, Leerink Partners LLC (February 25, 2015)
Underwriting Agreements
Celldex Therapeutics, Inc.
Biotechnology
NY
2015
Celldex Therapeutics, Inc. and BIOSYN Corporation Subscription Agreement (October 15, 2014)
Subscription Agreements
Celldex Therapeutics, Inc.
Biotechnology
DE
2014
Underwriting Agreement among Celldex Therapeutics, Inc., Jefferies LLC, Leerink Swann LLC, and Selling Stockholders (December 4, 2013)
Underwriting Agreements
Celldex Therapeutics, Inc.
Biotechnology
NY
2013
Celldex Therapeutics, Inc. 2004 Employee Stock Purchase Plan (as amended March 6, 2013)
Equity Distribution Agreements
Celldex Therapeutics, Inc.
Biotechnology
2013
Underwriting Agreement between Celldex Therapeutics, Inc. and Jefferies & Company, Inc. and Leerink Swann LLC (February 5, 2013)
Underwriting Agreements
Celldex Therapeutics, Inc.
Biotechnology
NY
2013
Amendment No. 1 to Sales Agreement between Celldex Therapeutics, Inc. and Cantor Fitzgerald & Co.
Equity Distribution Agreements
Celldex Therapeutics, Inc.
Biotechnology
NY
2012
Second Loan Modification Agreement among MidCap Funding V, LLC, General Electric Capital Corporation, Celldex Therapeutics, Inc., and Celldex Research Corporation
Modification Agreements
Celldex Therapeutics, Inc.
Biotechnology
MD
2012
Underwriting Agreement between Celldex Therapeutics, Inc. and Jefferies & Company, Inc. (February 24, 2012)
Underwriting Agreements
Celldex Therapeutics, Inc.
Biotechnology
NY
2012
Amendment to Master Services Agreement between Celldex Therapeutics, Inc. and Novella Clinical Inc.
Modification Agreements
Celldex Therapeutics, Inc.
Biotechnology
2011
Underwriting Agreement between Celldex Therapeutics, Inc. and Jefferies & Company, Inc. (May 18, 2011)
Underwriting Agreements
Celldex Therapeutics, Inc.
Biotechnology
NY
2011
Secured Promissory Note between Celldex Therapeutics, Inc., Celldex Research Corporation, and General Electric Capital Corporation (March 7, 2011)
Note Agreements
Celldex Therapeutics, Inc.
Biotechnology
2011
Joinder and First Loan Modification Agreement among MidCap Funding V, LLC, General Electric Capital Corporation, Celldex Therapeutics, Inc., and Celldex Research Corporation
Modification Agreements
Celldex Therapeutics, Inc.
Biotechnology
MD
2011
Controlled Equity Offering Sales Agreement between Celldex Therapeutics, Inc. and Cantor Fitzgerald & Co.
Equity Distribution Agreements
Celldex Therapeutics, Inc.
Biotechnology
NY
2011
Secured Promissory Note between Celldex Therapeutics, Inc., Celldex Research Corporation, and MidCap Financial, LLC (December 30, 2010)
Note Agreements
Celldex Therapeutics, Inc.
Biotechnology
2011
Celldex Therapeutics, Inc. Restricted Stock Award Agreement with Awardee under 2008 Stock Option and Incentive Plan
Stock Agreements
Celldex Therapeutics, Inc.
Biotechnology
DE
2010
Curagen Corporation and The Bank of New York Indenture for 4.0% Convertible Subordinated Notes Due 2011
Indenture Agreements
Celldex Therapeutics, Inc.
Biotechnology
NY
2010
Second Supplemental Indenture among CuraGen Corporation, Celldex Therapeutics, Inc., and The Bank of New York Mellon (Trustee)
Indenture Agreements
Celldex Therapeutics, Inc.
Biotechnology
NY
2009
Supplemental Indenture to 4.0% Convertible Subordinated Notes Due 2011 between CuraGen Corporation, Celldex Therapeutics, Inc., and The Bank of New York Mellon
Indenture Agreements
Celldex Therapeutics, Inc.
Biotechnology
NY
2009
Common Stock Purchase Agreement between Avant Immunotherapeutics, Inc. and Pfizer Vaccines LLC (May 2008)
Purchase Agreements
Celldex Therapeutics, Inc.
Biotechnology
DE
2008
Amendment Agreement to Purchase Agreement between AVANT Immunotherapeutics, Inc. and PRF Vaccine Holdings LLC
Modification Agreements
Celldex Therapeutics, Inc.
Biotechnology
2006
Amendment No. 1 to Asset Purchase Agreement between Celldex Therapeutics, Inc. and Alteris Therapeutics, Inc.
Modification Agreements
Celldex Therapeutics, Inc.
Biotechnology
NJ
2005
Underwriting Agreement for Common Stock Offering between Celldex Therapeutics, Inc. and Underwriters (Janney Montgomery Scott LLC and ThinkEquity Partners LLC)
Underwriting Agreements
Celldex Therapeutics, Inc.
Biotechnology
2005
Purchase Agreement between AVANT Immunotherapeutics, Inc. and PRF Vaccine Holdings LLC dated May 16, 2005
Purchase Agreements
Celldex Therapeutics, Inc.
Biotechnology
DE
2005
Amendment No. 1 to Asset Purchase Agreement between Celldex Therapeutics, Inc. and Alteris Therapeutics, Inc.
Purchase Agreements
Celldex Therapeutics, Inc.
Biotechnology
NJ
2005
Shareholder Rights Agreement between AVANT Immunotherapeutics, Inc. and EquiServe Trust Company, N.A. (November 5, 2004)
Shareholders Agreements
Celldex Therapeutics, Inc.
Biotechnology
DE
2004
Loan and Security Agreement among MidCap Financial, LLC, Lenders, Celldex Therapeutics, Inc., and Celldex Research Corporation dated December 30, 2010
Loan Agreements
Celldex Therapeutics, Inc.
Biotechnology
MD
2011